Testing a new malaria drug combination in healthy volunteers
Part of Infections clinical trials.
This study tests a new combination of three malaria drugs in healthy adults to see how safe they are and how the body handles them. It helps find the right dose for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old and weigh between 45 and 85 kg.
- You are a non-smoker and generally healthy.
- If you are a woman, you must not be pregnant or breastfeeding and must use effective birth control if you could become pregnant.
- You have a normal heart rhythm (ECG) and no history of heart problems.
- You have not taken any malaria drugs in the last 6 months.
- You can avoid alcohol for 48 hours before each dose and during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different malaria vaccines to see which is safer and works better. Participants will receive one of the vaccines and then be exposed to a safe form of the malaria parasite to check if it protects them.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
This study compares a combination of three medicines to treat uncomplicated malaria, to see if it works as well and is as well tolerated as a two-medicine combination. You may join if you have a specific type of malaria infection in a mild form and meet safety requirements.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.